Fuad El-Hibri Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Fuad El-Hibri.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Fuad El-Hibri. Fuad El-Hibri is Chairman in Emergent BioSolutions Inc. ($EBS) and Executive Chairman in Emergent BioSolutions Inc. ($EBS) and President, CEO & Chairman in Emergent BioSolutions Inc. ($EBS) and Board of Directors in Aptevo Therapeutics Inc. ($APVO) and Director in Aptevo Therapeutics Inc. ($APVO).
Latest Insider Trading Transactions of Fuad El-Hibri
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 0.00 | 893 | 0 | 893 | |
Jun 02 2021 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 26.15 | 2,678 | 70,030 | 2,678 | |
Feb 26 2021 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 13,906 | 0 | 13,906 | |
Feb 26 2021 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 93.49 | 27,808 | 2,599,770 | 27,808 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 | |
Nov 12 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 26.45 | 19,391 | 512,892 | 0 | |
Nov 12 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 26.45 | 20,000 | 529,000 | 19,391 | |
Nov 12 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 88.21 | 19,391 | 1,710,480 | 1,123,988 | 1.1 M to 1.1 M (-1.70 %) |
Nov 12 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 26.45 | 19,391 | 512,892 | 1,143,379 | 1.1 M to 1.1 M (+1.73 %) |
Nov 12 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 95.26 | 20,000 | 1,905,200 | 1,123,988 | 1.1 M to 1.1 M (-1.75 %) |
Nov 12 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 26.45 | 20,000 | 529,000 | 1,143,988 | 1.1 M to 1.1 M (+1.78 %) |
Nov 04 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 26.45 | 20,000 | 529,000 | 39,391 | |
Nov 04 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 26.45 | 20,000 | 529,000 | 59,391 | |
Nov 04 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 90.74 | 20,000 | 1,814,800 | 1,123,988 | 1.1 M to 1.1 M (-1.75 %) |
Nov 04 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 26.45 | 20,000 | 529,000 | 1,143,988 | 1.1 M to 1.1 M (+1.78 %) |
Nov 04 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 90.44 | 20,000 | 1,808,800 | 1,123,988 | 1.1 M to 1.1 M (-1.75 %) |
Nov 04 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 26.45 | 20,000 | 529,000 | 1,143,988 | 1.1 M to 1.1 M (+1.78 %) |
Sep 25 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 98.85 | 12,535 | 1,239,085 | 1,123,988 | 1.1 M to 1.1 M (-1.10 %) |
Sep 25 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 100.58 | 13,000 | 1,307,540 | 1,136,523 | 1.1 M to 1.1 M (-1.13 %) |
Sep 18 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 100.68 | 20,000 | 2,013,600 | 1,149,523 | 1.2 M to 1.1 M (-1.71 %) |
Sep 18 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 102.48 | 20,000 | 2,049,600 | 1,169,523 | 1.2 M to 1.2 M (-1.68 %) |
Sep 11 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 102.66 | 20,000 | 2,053,200 | 1,189,523 | 1.2 M to 1.2 M (-1.65 %) |
Sep 11 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 102.66 | 20,000 | 2,053,200 | 1,189,523 | 1.2 M to 1.2 M (-1.65 %) |
Sep 11 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 102.80 | 20,000 | 2,056,000 | 1,209,523 | 1.2 M to 1.2 M (-1.63 %) |
Sep 11 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 102.80 | 20,000 | 2,056,000 | 1,209,523 | 1.2 M to 1.2 M (-1.63 %) |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
May 01 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 74.01 | 20,000 | 1,480,200 | 1,229,523 | 1.2 M to 1.2 M (-1.60 %) |
May 01 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 74.24 | 20,000 | 1,484,800 | 1,249,523 | 1.3 M to 1.2 M (-1.58 %) |
Apr 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 68.49 | 20,000 | 1,369,800 | 1,269,523 | 1.3 M to 1.3 M (-1.55 %) |
Apr 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 66.81 | 20,000 | 1,336,200 | 1,289,523 | 1.3 M to 1.3 M (-1.53 %) |
Apr 20 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 62.47 | 20,000 | 1,249,400 | 1,309,523 | 1.3 M to 1.3 M (-1.50 %) |
Apr 15 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 62.58 | 12,537 | 784,565 | 1,329,523 | 1.3 M to 1.3 M (-0.93 %) |
Apr 15 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 62.99 | 6,261 | 394,380 | 1,342,060 | 1.3 M to 1.3 M (-0.46 %) |
Apr 15 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 62.25 | 17,071 | 1,062,670 | 1,348,321 | 1.4 M to 1.3 M (-1.25 %) |
Apr 10 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 61.83 | 23,716 | 1,466,360 | 1,365,392 | 1.4 M to 1.4 M (-1.71 %) |
Apr 10 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 61.83 | 23,716 | 1,466,360 | 1,365,392 | 1.4 M to 1.4 M (-1.71 %) |
Apr 10 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 61.34 | 24,362 | 1,494,365 | 1,389,108 | 1.4 M to 1.4 M (-1.72 %) |
Apr 10 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 61.34 | 24,362 | 1,494,365 | 1,389,108 | 1.4 M to 1.4 M (-1.72 %) |
Apr 10 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 60.75 | 13,000 | 789,750 | 1,413,470 | 1.4 M to 1.4 M (-0.91 %) |
Apr 10 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 60.75 | 13,000 | 789,750 | 1,413,470 | 1.4 M to 1.4 M (-0.91 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 60.76 | 14,336 | 871,055 | 1,426,470 | 1.4 M to 1.4 M (-0.99 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 60.50 | 28,240 | 1,708,520 | 1,440,806 | 1.5 M to 1.4 M (-1.92 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 60.76 | 14,336 | 871,055 | 1,426,470 | 1.4 M to 1.4 M (-0.99 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 60.50 | 28,240 | 1,708,520 | 1,440,806 | 1.5 M to 1.4 M (-1.92 %) |
Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,794 | 0 | 37,980 | |
Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 6,429 | 0 | 47,774 | |
Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 56.97 | 9,837 | 560,414 | 1,469,046 | 1.5 M to 1.5 M (-0.67 %) |
Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 58.42 | 3,854 | 225,151 | 1,478,883 | 1.5 M to 1.5 M (-0.26 %) |
Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,794 | 0 | 1,482,737 | 1.5 M to 1.5 M (+0.66 %) |
Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 58.70 | 13,619 | 799,435 | 1,472,943 | 1.5 M to 1.5 M (-0.92 %) |
Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 59.91 | 2,530 | 151,572 | 1,486,562 | 1.5 M to 1.5 M (-0.17 %) |
Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 6,429 | 0 | 1,489,092 | 1.5 M to 1.5 M (+0.43 %) |
Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 59.91 | 2,365 | 141,687 | 1,482,663 | 1.5 M to 1.5 M (-0.16 %) |
Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 6,010 | 0 | 54,203 | |
Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 6,010 | 0 | 54,203 | |
Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 19,532 | 0 | 60,213 | |
Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 19,532 | 0 | 60,213 | |
Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 61.44 | 39,061 | 2,399,908 | 39,061 | |
Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 61.44 | 39,061 | 2,399,908 | 39,061 | |
Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 6,010 | 0 | 1,485,028 | 1.5 M to 1.5 M (+0.41 %) |
Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 6,010 | 0 | 1,485,028 | 1.5 M to 1.5 M (+0.41 %) |
Feb 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 25.62 | 18,567 | 475,687 | 0 | |
Feb 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 25.62 | 4,751 | 121,721 | 18,567 | |
Feb 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 64.90 | 18,567 | 1,204,998 | 1,479,018 | 1.5 M to 1.5 M (-1.24 %) |
Feb 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 25.62 | 18,567 | 475,687 | 1,497,585 | 1.5 M to 1.5 M (+1.26 %) |
Feb 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 64.90 | 4,751 | 308,340 | 1,479,018 | 1.5 M to 1.5 M (-0.32 %) |
Feb 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 25.62 | 4,751 | 121,721 | 1,483,769 | 1.5 M to 1.5 M (+0.32 %) |
Feb 19 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 25.62 | 15,614 | 400,031 | 23,318 | |
Feb 19 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 25.62 | 4,386 | 112,369 | 38,932 | |
Feb 19 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 63.90 | 15,614 | 997,735 | 1,479,018 | 1.5 M to 1.5 M (-1.04 %) |
Feb 19 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 25.62 | 15,614 | 400,031 | 1,494,632 | 1.5 M to 1.5 M (+1.06 %) |
Feb 19 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 63.90 | 4,386 | 280,265 | 1,479,018 | 1.5 M to 1.5 M (-0.30 %) |
Feb 19 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 25.62 | 4,386 | 112,369 | 1,483,404 | 1.5 M to 1.5 M (+0.30 %) |
Feb 13 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 25.62 | 13,720 | 351,506 | 43,318 | |
Feb 13 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 25.62 | 6,280 | 160,894 | 57,038 | |
Feb 13 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 62.90 | 13,720 | 862,988 | 1,479,018 | 1.5 M to 1.5 M (-0.92 %) |
Feb 13 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 25.62 | 13,720 | 351,506 | 1,492,738 | 1.5 M to 1.5 M (+0.93 %) |
Feb 13 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 62.90 | 6,280 | 395,012 | 1,479,018 | 1.5 M to 1.5 M (-0.42 %) |
Feb 13 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 25.62 | 6,280 | 160,894 | 1,485,298 | 1.5 M to 1.5 M (+0.42 %) |
Feb 07 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Executive Chairman | Sell | S | 61.90 | 11,684 | 723,240 | 1,419,018 | 1.4 M to 1.4 M (-0.82 %) |
Feb 07 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Executive Chairman | Sell | S | 60.66 | 48,316 | 2,930,849 | 1,430,702 | 1.5 M to 1.4 M (-3.27 %) |
Aug 13 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Buy | P | 0.76 | 100,000 | 75,520 | 1,124,536 | 1 M to 1.1 M (+9.76 %) |
Jul 30 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.83 | 55,015 | 45,861 | 1,024,536 | 969.5 K to 1 M (+5.67 %) |
Jul 24 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.90 | 10,000 | 8,996 | 969,521 | 959.5 K to 969.5 K (+1.04 %) |
Jul 23 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.89 | 30,000 | 26,601 | 959,521 | 929.5 K to 959.5 K (+3.23 %) |
Jul 19 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.90 | 26,460 | 23,740 | 929,521 | 903.1 K to 929.5 K (+2.93 %) |
Jul 18 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.87 | 14,404 | 12,596 | 903,061 | 888.7 K to 903.1 K (+1.62 %) |
Jul 18 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.87 | 19,136 | 16,704 | 888,657 | 869.5 K to 888.7 K (+2.20 %) |
Jul 16 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.85 | 11,375 | 9,662 | 869,521 | 858.1 K to 869.5 K (+1.33 %) |
Jul 12 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.85 | 14,691 | 12,454 | 858,146 | 843.5 K to 858.1 K (+1.74 %) |
Jul 11 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Buy | P | 0.85 | 18,919 | 16,058 | 843,455 | 824.5 K to 843.5 K (+2.29 %) |
Jun 04 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Option Exercise | A | 0.73 | 25,000 | 18,125 | 25,000 | |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,722 | 0 | 40,681 | |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,794 | 0 | 50,403 | |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 61.01 | 36,053 | 2,199,594 | 36,053 | |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 18,029 | 0 | 60,197 | |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 6,430 | 0 | 42,168 | |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 58.71 | 3,826 | 224,624 | 1,479,018 | 1.5 M to 1.5 M (-0.26 %) |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,722 | 0 | 1,482,844 | 1.5 M to 1.5 M (+0.66 %) |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 58.47 | 6,987 | 408,530 | 1,473,122 | 1.5 M to 1.5 M (-0.47 %) |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 57.98 | 2,486 | 144,138 | 1,480,109 | 1.5 M to 1.5 M (-0.17 %) |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,794 | 0 | 1,482,595 | 1.5 M to 1.5 M (+0.66 %) |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 58.24 | 10,369 | 603,891 | 1,472,801 | 1.5 M to 1.5 M (-0.70 %) |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 61.01 | 1,566 | 95,542 | 1,483,170 | 1.5 M to 1.5 M (-0.11 %) |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 6,430 | 0 | 1,484,736 | 1.5 M to 1.5 M (+0.43 %) |
Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 59.65 | 10,369 | 618,511 | 1,478,306 | 1.5 M to 1.5 M (-0.70 %) |
Nov 28 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 69.59 | 20,832 | 1,449,699 | 1,407,670 | 1.4 M to 1.4 M (-1.46 %) |
Nov 28 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 69.96 | 25,000 | 1,749,000 | 1,428,502 | 1.5 M to 1.4 M (-1.72 %) |
Nov 21 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 70.03 | 15,173 | 1,062,565 | 1,453,502 | 1.5 M to 1.5 M (-1.03 %) |
Nov 21 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 69.54 | 20,000 | 1,390,800 | 1,468,675 | 1.5 M to 1.5 M (-1.34 %) |
Aug 15 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 56.57 | 16,318 | 923,109 | 1,488,675 | 1.5 M to 1.5 M (-1.08 %) |
Aug 15 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 55.50 | 20,000 | 1,110,000 | 1,504,993 | 1.5 M to 1.5 M (-1.31 %) |
Jul 16 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 54.52 | 2,600 | 141,752 | 1,524,993 | 1.5 M to 1.5 M (-0.17 %) |
Jul 16 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 54.50 | 12,400 | 675,800 | 1,527,593 | 1.5 M to 1.5 M (-0.81 %) |
Jul 11 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 53.61 | 15,000 | 804,150 | 1,539,993 | 1.6 M to 1.5 M (-0.96 %) |
Jun 04 2018 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 5.49 | 25,000 | 137,250 | 25,000 | |
Mar 13 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 13,237 | 0 | 48,598 | |
Mar 13 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 51.84 | 3,224 | 167,132 | 1,554,993 | 1.6 M to 1.6 M (-0.21 %) |
Mar 13 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 13,237 | 0 | 1,558,217 | 1.5 M to 1.6 M (+0.86 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,723 | 0 | 61,835 | |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,794 | 0 | 71,558 | |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 49.64 | 38,577 | 1,914,962 | 38,577 | |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 19,288 | 0 | 81,352 | |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 49.97 | 2,368 | 118,329 | 1,544,980 | 1.5 M to 1.5 M (-0.15 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,723 | 0 | 1,547,348 | 1.5 M to 1.5 M (+0.63 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 49.64 | 2,385 | 118,391 | 1,537,625 | 1.5 M to 1.5 M (-0.15 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,794 | 0 | 1,540,010 | 1.5 M to 1.5 M (+0.64 %) |
Nov 30 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 22.03 | 27,983 | 616,465 | 0 | |
Nov 30 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 22.03 | 20,000 | 440,600 | 27,983 | |
Nov 30 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 42.08 | 27,983 | 1,177,525 | 1,530,216 | 1.6 M to 1.5 M (-1.80 %) |
Nov 30 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 22.03 | 27,983 | 616,465 | 1,558,199 | 1.5 M to 1.6 M (+1.83 %) |
Nov 30 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 41.59 | 20,000 | 831,800 | 1,530,216 | 1.6 M to 1.5 M (-1.29 %) |
Nov 30 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 22.03 | 20,000 | 440,600 | 1,550,216 | 1.5 M to 1.6 M (+1.31 %) |
Nov 15 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 40.05 | 20,000 | 801,000 | 1,490,216 | 1.5 M to 1.5 M (-1.32 %) |
Nov 15 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 40.69 | 20,000 | 813,800 | 1,510,216 | 1.5 M to 1.5 M (-1.31 %) |
Sep 29 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 40.50 | 25,000 | 1,012,500 | 1,530,216 | 1.6 M to 1.5 M (-1.61 %) |
Sep 29 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 39.50 | 25,000 | 987,500 | 1,555,216 | 1.6 M to 1.6 M (-1.58 %) |
Sep 14 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 38.50 | 23,547 | 906,560 | 1,580,216 | 1.6 M to 1.6 M (-1.47 %) |
Sep 14 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 38.50 | 1,453 | 55,941 | 1,603,763 | 1.6 M to 1.6 M (-0.09 %) |
Sep 08 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 37.50 | 16,439 | 616,463 | 1,605,216 | 1.6 M to 1.6 M (-1.01 %) |
Sep 06 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 37.50 | 3,100 | 116,250 | 1,621,655 | 1.6 M to 1.6 M (-0.19 %) |
Sep 01 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 37.50 | 5,461 | 204,788 | 1,624,755 | 1.6 M to 1.6 M (-0.33 %) |
Jul 28 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 36.50 | 25,000 | 912,500 | 1,630,216 | 1.7 M to 1.6 M (-1.51 %) |
Jul 21 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 35.50 | 25,000 | 887,500 | 1,655,216 | 1.7 M to 1.7 M (-1.49 %) |
Jun 01 2017 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 2.15 | 12,500 | 26,875 | 12,500 | |
Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 20,554 | 0 | 62,064 |